Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach

Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach

The sudden outbreak of novel coronavirus has caused a global concern due to its infection rate and mortality. Despite extensive research, there are still no specific drugs or vaccines to combat SARS-CoV-2 infection. Hence, this study was designed to evaluate some plant-based active compounds for dru...

Full description

Bibliographic Details
Main Authors:	Kazi Faizul Azim, Sheikh Rashel Ahmed, Anik Banik, Md Mostafigur Rahman Khan, Anamika Deb, Saneya Risa Somana
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Informatics in Medicine Unlocked
Subjects:	SARS-CoV-2 Plant metabolites Main protease proteins Molecular docking ADME analysis Drug target
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352914820303622

Similar Items

Targeting mucormycosis polyprotein (RVT_1 region) through antifungal phytochemicals: An in-silico perspective
by: Anik Banik, et al.
Published: (2022-01-01)

Inhibitory potential of plant-derived metabolites against Zika virus: a computational-aided approach
by: Sheikh Rashel Ahmed, et al.
Published: (2021-11-01)

In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)
by: Elham Aghaee, et al.
Published: (2021-01-01)

In Silico Evaluation of Different Flavonoids from Medicinal Plants for Their Potency against SARS-CoV-2
by: H. R. Abd El-Mageed, et al.
Published: (2021-11-01)

Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation
by: Aganze G. Mushebenge, et al.
Published: (2023-03-01)

Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation
by: Asim Kumar Bepari, et al.
Published: (2021-04-01)

Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study
by: Ishola Abeeb Akinwumi, et al.
Published: (2023-12-01)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020-11-01)

Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
by: Fangya Li, et al.
Published: (2023-06-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

Druggable targets and therapeutic development for COVID-19
by: Xiaohua Duan, et al.
Published: (2022-10-01)

Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method
by: Suwicha Patnin, et al.
Published: (2022-03-01)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-07-01)

A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
by: Alejandro Llanes, et al.
Published: (2020-12-01)

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
by: Vishma Pratap Sur, et al.
Published: (2021-10-01)

Discovery of anti-SARS-CoV-2 agents from 38 Chinese patent drugs toward respiratory diseases via docking screening
by: Yong-Ming Yan, et al.
Published: (2023-02-01)

Blue Biotechnology: Computational Screening of <i>Sarcophyton</i> Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition
by: Mahmoud A. A. Ibrahim, et al.
Published: (2021-07-01)

Identification of novel drug targets and screening potential drugs against Cryptococcus gattii: An in silico approach
by: Tanjin Barketullah Robin, et al.
Published: (2023-01-01)

Discovery of anti-SARS-CoV-2 agents from commercially available flavor via docking screening
by: Jiaojiao Zhang, et al.
Published: (2023-02-01)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
by: Wenfa Zhang, et al.
Published: (2023-02-01)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
by: Annamaria Martorana, et al.
Published: (2020-07-01)

Investigation of plant metabolites as potential inhibitors of Acinetobacter baumannii: An In-Silico approach
by: Jamil Ahmed, et al.
Published: (2023-01-01)

New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture
by: Alexey Sulimov, et al.
Published: (2022-09-01)

In silico, 6LU7 protein inhibition using dihydroxy-3-phenyl coumarin derivatives for SARS-CoV-2
by: Mücahit Özdemir, et al.
Published: (2020-10-01)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)

Computational Identification of Druggable Bioactive Compounds from <i>Catharanthus roseus</i> and <i>Avicennia marina</i> against Colorectal Cancer by Targeting Thymidylate Synthase
by: Md Rashedul Islam, et al.
Published: (2022-03-01)

A computational approach to identify novel plant metabolites against Aspergillus fumigatus
by: Jamil Ahmed, et al.
Published: (2023-01-01)

Syzygium aromaticum as a possible source of SARS-CoV-2 main protease inhibitors: Evidence from a computational investigation
by: Md. Chayan Ali, et al.
Published: (2022-04-01)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
by: Mehdi Oubahmane, et al.
Published: (2023-04-01)

Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach
by: Oluwasayo Peter Abodunrin, et al.
Published: (2022-01-01)

Molecular Docking and Interaction Analysis of Propolis Compounds Against SARS-CoV-2 Receptor
by: Mokhamad Fahmi Rizki Syaban, et al.
Published: (2022-05-01)

Computational guided identification of potential leads from Acacia pennata (L.) Willd. as inhibitors for cellular entry and viral replication of SARS-CoV-2
by: James H. Zothantluanga, et al.
Published: (2021-10-01)

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
by: Panthakarn Rangsinth, et al.
Published: (2021-03-01)

In silico analysis of selected components of grapefruit seed extract against SARS-CoV-2 main protease
by: Saric Belmina, et al.
Published: (2021-06-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
by: Maryam Abbasi, et al.
Published: (2024-01-01)

In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Main Protease among a PubChem Database of Avian Infectious Bronchitis Virus 3CLPro Inhibitors
by: Laurent Soulère, et al.
Published: (2023-06-01)

Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies
by: Raju Das, et al.
Published: (2023-02-01)

Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
by: Aniruddhya Mukherjee, et al.
Published: (2023-07-01)

Synthesis, spectral analysis, DFT studies and Biological application of (E)-3-benzylidene-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one
by: Rathinam Sankar, et al.
Published: (2024-06-01)